ecoporc shiga
ceva santé animale - genetically modified recombinant shiga-toxin-2e antigen - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - pigs - active immunisation of piglets from the age of four days, to reduce the mortality and clinical signs of oedema disease caused by shiga toxin 2e produced by escherichia coli (stec). onset of immunity: 21 days after vaccination. duration of immunity: 105 days after vaccination.,
pharmaceutical information system application software
doseme pty ltd - 58842 - pharmaceutical information system application software - doseme is a software application program, containing bayesian dosing algorithms, intended for drug dosage decision support and use as an information system to store, manage and assist in the analysis of patient data within healthcare facilities. doseme assists with the dose management of therapeutic pharmaceuticals. the system has functionality to aid in dosing, in particular allowing for dosing adjustment when required by drug interactions. the device is available as an app for use on portable smart devices and for use via a web interface on many types of computers and networks.
pharmaceutical management support software
ferring pharmaceuticals pty ltd -
pharmaceutical information system application software
cerner corporation pty ltd - 58842 - pharmaceutical information system application software - an application , routine, and/or algorithm intended for use as or in an information system to receive, collect, store, manage,assist in analysis of, display, output and distribute data within or between healthcare facilities, to assist with therapeutic pharmaceutical prescription and management
ropinirole jenson pharmaceutical services 5 mg, comprimé pelliculé
jenson pharmaceutical services ltd - ropinirole base - comprimé - 5 mg - composition pour un comprimé > ropinirole base : 5 mg . sous forme de : chlorhydrate de ropinirole 5,7 mg - antiparkinsonien dopaminergique
oxaliplatino sun pharmaceutical industries europe
sun pharmaceutical industries (europe) b.v. - oxaliplatino - oxaliplatino
quetiapine intas pharmaceuticals 50 mg comprimé à libération prolongée
intas pharmaceuticals - fumarate de quétiapine - comprimé à libération prolongée - 50 mg - fumarate de quétiapine 57.575 mg - quetiapine
quetiapine intas pharmaceuticals 200 mg comprimé à libération prolongée
intas pharmaceuticals - fumarate de quétiapine - comprimé à libération prolongée - 200 mg - fumarate de quétiapine 230.3 mg - quetiapine
quetiapine intas pharmaceuticals 300 mg comprimé à libération prolongée
intas pharmaceuticals - fumarate de quétiapine - comprimé à libération prolongée - 300 mg - fumarate de quétiapine 345.45 mg - quetiapine
quetiapine intas pharmaceuticals 400 mg comprimé à libération prolongée
intas pharmaceuticals - fumarate de quétiapine - comprimé à libération prolongée - 400 mg - fumarate de quétiapine 460.6 mg - quetiapine